These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19670728)

  • 41. Cancer research. Looking for a target on every tumor.
    Kaiser J
    Science; 2009 Oct; 326(5950):218-20. PubMed ID: 19815749
    [No Abstract]   [Full Text] [Related]  

  • 42. Targeting the hypoxia-inducible factor (HIF) pathway in cancer.
    Poon E; Harris AL; Ashcroft M
    Expert Rev Mol Med; 2009 Aug; 11():e26. PubMed ID: 19709449
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.
    Roukos DH; Tzakos A; Zografos G
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1413-6. PubMed ID: 19828000
    [No Abstract]   [Full Text] [Related]  

  • 44. [Establishment of reporter gene-based cell screening model for discovering new chemopreventive agents].
    Xu H; Bu P; Li X
    Zhongguo Zhong Yao Za Zhi; 2009 Jul; 34(14):1835-9. PubMed ID: 19894520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Application of peptide bioregulators in gerontology: results and perspectives].
    Khavinson VKh; Morozov VG
    Klin Med (Mosk); 2000; 78(8):81-4. PubMed ID: 11019535
    [No Abstract]   [Full Text] [Related]  

  • 46. Doxazosin-related alpha1-adrenoceptor antagonists with prostate antitumor activity.
    Giardinà D; Martarelli D; Sagratini G; Angeli P; Ballinari D; Gulini U; Melchiorre C; Poggesi E; Pompei P
    J Med Chem; 2009 Aug; 52(15):4951-4. PubMed ID: 19719240
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Marine life: new hope for cancer drugs.
    Jain R
    Indian J Cancer; 2009; 46(3):243-4. PubMed ID: 19574681
    [No Abstract]   [Full Text] [Related]  

  • 48. Platinum drug distribution in cancer cells and tumors.
    Klein AV; Hambley TW
    Chem Rev; 2009 Oct; 109(10):4911-20. PubMed ID: 19711978
    [No Abstract]   [Full Text] [Related]  

  • 49. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity.
    Shin SW; Seo CY; Han H; Han JY; Jeong JS; Kwak JY; Park JI
    Clin Cancer Res; 2009 Sep; 15(17):5414-25. PubMed ID: 19690198
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting the EGF receptor ectodomain in the context of cancer.
    Huang L; De Baetselier P; Beyaert R
    Expert Opin Ther Targets; 2009 Nov; 13(11):1347-61. PubMed ID: 19769546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification.
    You QD; Li ZY; Huang CH; Yang Q; Wang XJ; Guo QL; Chen XG; He XG; Li TK; Chern JW
    J Med Chem; 2009 Sep; 52(18):5649-61. PubMed ID: 19715319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vitamin D analogs in cancer prevention and therapy: an ancient friend revisited.
    Reichrath J; Tilgen W; Diedrich K; Friedrich M
    Anticancer Res; 2009 Sep; 29(9):3469-70. PubMed ID: 19667140
    [No Abstract]   [Full Text] [Related]  

  • 53. SC68896, a novel small molecule proteasome inhibitor, exerts antiglioma activity in vitro and in vivo.
    Roth P; Kissel M; Herrmann C; Eisele G; Leban J; Weller M; Schmidt F
    Clin Cancer Res; 2009 Nov; 15(21):6609-18. PubMed ID: 19825946
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of type 3 deiodinase in cancer.
    Dentice M; Ambrosio R; Salvatore D
    Expert Opin Ther Targets; 2009 Nov; 13(11):1363-73. PubMed ID: 19764892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth.
    Iljin K; Ketola K; Vainio P; Halonen P; Kohonen P; Fey V; Grafström RC; Perälä M; Kallioniemi O
    Clin Cancer Res; 2009 Oct; 15(19):6070-8. PubMed ID: 19789329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activated CD4+ T cells dramatically enhance chemotherapeutic tumor responses in vitro and in vivo.
    Radfar S; Wang Y; Khong HT
    J Immunol; 2009 Nov; 183(10):6800-7. PubMed ID: 19846868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 5-Azacytidine prevents cisplatin induced nephrotoxicity and potentiates anticancer activity of cisplatin by involving inhibition of metallothionein, pAKT and DNMT1 expression in chemical induced cancer rats.
    Tikoo K; Ali IY; Gupta J; Gupta C
    Toxicol Lett; 2009 Dec; 191(2-3):158-66. PubMed ID: 19723570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro impact of a whey protein isolate (WPI) and collagen hydrolysates (CHs) on B16F10 melanoma cells proliferation.
    Castro GA; Maria DA; Bouhallab S; Sgarbieri VC
    J Dermatol Sci; 2009 Oct; 56(1):51-7. PubMed ID: 19695839
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Older patients and the shifting focus of cancer care.
    Lichtman SM
    Oncology (Williston Park); 2009 Jan; 23(1):86, 88. PubMed ID: 19283926
    [No Abstract]   [Full Text] [Related]  

  • 60. Synthesis of gibberellin derivatives with anti-tumor bioactivities.
    Chen J; Sun Z; Zhang Y; Zeng X; Qing C; Liu J; Li L; Zhang H
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5496-9. PubMed ID: 19679470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.